Scandinavian Biopharma Distribution ApS — Credit Rating and Financial Key Figures
CVR number: 44809028
Lautrupsgade 11, 2100 København Ø
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | 371.24 |
| Employee benefit expenses | - 340.18 |
| EBIT | 31.06 |
| Other financial income | 1.03 |
| Other financial expenses | -2.56 |
| Pre-tax profit | 29.52 |
| Income taxes | -7.81 |
| Net earnings | 21.71 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | 19.00 |
| Long term receivables total | |
| Raw materials and consumables | 1 579.30 |
| Inventories total | 1 579.30 |
| Current trade debtors | 598.02 |
| Prepayments and accrued income | 2.69 |
| Current other receivables | 67.91 |
| Short term receivables total | 668.63 |
| Cash and bank deposits | 426.85 |
| Cash and cash equivalents | 426.85 |
| Balance sheet total (assets) | 2 693.78 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Profit of the financial year | 21.71 |
| Shareholders equity total | 61.71 |
| Non-current liabilities total | |
| Current trade creditors | 201.03 |
| Current owed to group member | 2 344.82 |
| Short-term deferred tax liabilities | 7.81 |
| Other non-interest bearing current liabilities | 78.40 |
| Current liabilities total | 2 632.06 |
| Balance sheet total (liabilities) | 2 693.78 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.